Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada

Documenti analoghi

• Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
  di: Sugimoto, T., et al.
  Pubblicazione: (2013)
• Treatment responses with once-weekly teriparatide therapy for osteoporosis
  di: Shiraki, M., et al.
  Pubblicazione: (2016)
• Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
  di: Sugimoto, T., et al.
  Pubblicazione: (2019)
• New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
  di: Tanaka, Sakae, et al.
  Pubblicazione: (2014)
• Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
  di: Shiraki, M., et al.
  Pubblicazione: (2012)